Crossmark

OCT-4: a novel estrogen receptor-α collaborator that promotes tamoxifen resistance in breast cancer cells

Published Online: 2016-04-11

Published Print: 2016-11-03

Authors

Bhatt, S

Stender, J D

Joshi, S

Wu, G

Katzenellenbogen, B S
License Information

Text and Data Mining valid from 2016-04-11

Version of Record valid from 2016-04-11
More Information

Article History

Received: 27 March 2015

Revised: 20 November 2015

Accepted: 8 January 2016

First Online: 11 April 2016

Competing interests

: The authors declare no conflict of interest.

Document is current